0,858  0,003  CTGF expression inhibitor
0,760  0,006  CYP1A2 substrate
0,730  0,004  5 Hydroxytryptamine release inhibitor
0,716  0,007  CYP2C19 substrate
0,710  0,017  CYP3A4 substrate
0,691  0,004  Psychostimulant
0,683  0,007  NOS2 expression inhibitor
0,657  0,006  Histamine release inhibitor
0,647  0,002  Cannabinoid CB2 receptor antagonist
0,629  0,003  Neurotrophic factor enhancer
0,628  0,010  UGT1A9 substrate
0,601  0,005  Diabetic retinopathy treatment
0,579  0,006  Antianorexic
0,587  0,014  Spasmolytic
0,596  0,026  TNF expression inhibitor
0,578  0,011  Lipoxygenase inhibitor
0,566  0,025  CYP2C9 substrate
0,532  0,012  CYP1A2 inhibitor
0,535  0,016  Antioxidant
0,538  0,022  Antihypercholesterolemic
0,537  0,027  Cholesterol antagonist
0,516  0,009  Sedative
0,528  0,029  Teratogen
0,507  0,016  Free radical scavenger
0,545  0,070  Antiinflammatory
0,479  0,008  Melanin inhibitor
0,515  0,044  Alzheimer's disease treatment
0,513  0,042  Transcription factor NF kappa B inhibitor
0,470  0,015  UGT1A6 substrate
0,471  0,018  Antipyretic
0,461  0,016  Antidiabetic symptomatic
0,479  0,037  Atherosclerosis treatment
0,449  0,009  Antiseptic
0,462  0,026  AR expression inhibitor
0,457  0,023  Chemopreventive
0,466  0,034  Embryotoxic
0,432  0,004  Cannabinoid receptor antagonist
0,467  0,048  GST A substrate
0,424  0,009  Thrombolytic
0,426  0,019  Antihypertriglyceridemic
0,437  0,030  NOS3 expression inhibitor
0,416  0,012  Non-steroidal antiinflammatory agent
0,417  0,015  Antimutagenic
0,432  0,036  FMO1 substrate
0,404  0,010  Genotoxic
0,395  0,004  TRPA1 agonist
0,409  0,026  Hypoglycemic
0,392  0,010  Lipid peroxidase inhibitor
0,385  0,004  Cannabinoid CB1 receptor antagonist
0,405  0,026  Antiglaucomic
0,426  0,047  Ulceration
0,429  0,062  15-Lipoxygenase inhibitor
0,396  0,032  UGT2B4 substrate
0,448  0,084  Caspase 9 stimulant
0,402  0,040  Antihypertensive
0,366  0,005  SULT1A3 substrate
0,451  0,091  Apoptosis agonist
0,434  0,074  Cyclophilin D inhibitor
0,434  0,074  Antidiabetic
0,397  0,039  Lipoprotein disorders treatment
0,355  0,004  SULT1A1 substrate
0,429  0,079  Antiarthritic
0,395  0,051  Bone diseases treatment
0,408  0,063  Antipruritic, allergic
0,371  0,033  Mutagenic
0,371  0,034  Antiamyloidogenic
0,365  0,035  Cardiotonic
0,339  0,013  Protein kinase stimulant
0,358  0,032  Amyloid beta aggregation inhibitor
0,362  0,041  Chemoprotective
0,345  0,025  GST M1-1 substrate
0,383  0,070  Immunosuppressant
0,335  0,031  Peroxidase inhibitor
0,336  0,034  Nitric oxide antagonist
0,359  0,058  ICAM1 expression inhibitor
0,322  0,021  Contraceptive
0,338  0,038  Hypolipemic
0,342  0,045  Sensitization
0,302  0,005  Estrogen receptor alpha antagonist
0,339  0,043  Antiprotozoal (Leishmania)
0,309  0,017  Monophenol monooxygenase inhibitor
0,344  0,054  Cardioprotectant
0,322  0,035  5 Hydroxytryptamine uptake stimulant
0,327  0,041  Carcinogenic
0,314  0,029  UGT1A1 substrate
0,287  0,005  Coagulant
0,308  0,027  Antihypotensive
0,341  0,068  Antithrombotic
0,335  0,063  Vasodilator, coronary
0,321  0,051  FMO3 substrate
0,295  0,024  Pneumotoxic
0,332  0,064  12-Lipoxygenase inhibitor
0,281  0,014  Cholesterol synthesis inhibitor
0,301  0,035  Abortion inducer
0,278  0,022  Skin whitener
0,314  0,066  5 Hydroxytryptamine release stimulant
0,350  0,102  Antibacterial
0,253  0,005  Posttraumatic stress disorder treatment
0,313  0,069  Antiischemic
0,279  0,037  RNA-directed DNA polymerase inhibitor
0,293  0,054  Cardiovascular analeptic
0,323  0,086  Vasodilator, peripheral
0,241  0,006  Electron transport complex I inhibitor
0,301  0,066  Radioprotector
0,290  0,056  Proliferative diseases treatment
0,279  0,045  Tyrosine 3 hydroxylase inhibitor
0,260  0,028  UGT1A3 substrate
0,249  0,021  Cyclooxygenase 1 inhibitor
0,253  0,026  UGT2B15 substrate
0,281  0,055  Vasodilator
0,237  0,011  UGT2B1 substrate
0,324  0,099  CYP2C9 inhibitor
0,262  0,037  UGT2B7 substrate
0,250  0,026  Cyclooxygenase inhibitor
0,262  0,040  Growth hormone agonist
0,247  0,027  Prostate disorders treatment
0,236  0,017  Cystathionine beta-synthase inhibitor
0,299  0,081  Antifungal
0,260  0,046  UDP-glucuronosyltransferase substrate
0,246  0,033  Acaricide
0,289  0,077  Antineoplastic (ovarian cancer)
0,242  0,031  Hair growth stimulant
0,254  0,044  VCAM1 expression inhibitor
0,233  0,023  Cyclooxygenase 2 inhibitor
0,291  0,081  Respiratory analeptic
0,330  0,120  Antiparkinsonian
0,290  0,081  Analeptic
0,274  0,066  Antineoplastic (glioma)
0,306  0,099  Antileukemic
0,235  0,030  NOS3 expression enhancer
0,210  0,005  TRPA1 antagonist
0,212  0,008  Actinic keratosis treatment
0,291  0,088  Sodium/bile acid cotransporter inhibitor
0,221  0,020  5-Lipoxygenase inhibitor
0,208  0,008  Prolactin inhibitor
0,241  0,043  Muscle relaxant
0,240  0,042  CYP2B6 inhibitor
0,212  0,016  CF transmembrane conductance regulator agonist
0,205  0,011  Vanilloid 1 agonist
0,236  0,043  Insulin sensitizer
0,310  0,117  CYP2C19 inhibitor
0,215  0,024  DNA polymerase I inhibitor
0,254  0,064  Antineoplastic (sarcoma)
0,205  0,016  Sulfotransferase substrate
0,213  0,024  Antihyperlipoproteinemic
0,262  0,075  Flavin-containing monooxygenase substrate
0,275  0,089  Antipsoriatic
0,233  0,046  Antianginal
0,229  0,044  Antipruritic, non-allergic
0,303  0,118  Antineoplastic (breast cancer)
0,216  0,034  Carcinogenic, group 3
0,210  0,028  Antifungal enhancer
0,195  0,014  Sphingosine 1-phosphate receptor 5 antagonist
0,244  0,063  Cytotoxic
0,258  0,077  Amyotrophic lateral sclerosis treatment
0,204  0,026  Neurotrophic factor
0,184  0,007  Cannabinoid CB1 receptor agonist
0,234  0,058  Anesthetic general
0,183  0,007  Antifungal (Candida)
0,259  0,085  Antidiabetic (type 2)
0,277  0,104  Antiallergic
0,191  0,018  Adenylate cyclase stimulant
0,197  0,026  Proteasome inhibitor
0,190  0,020  Bronchodilator
0,182  0,014  Sphingosine 1-phosphate receptor 4 antagonist
0,290  0,123  GABA C receptor rho-3 antagonist
0,220  0,053  P-glycoprotein inhibitor
0,181  0,014  Sphingosine 1-phosphate receptor 2 antagonist
0,234  0,068  Antineoplastic (glioblastoma multiforme)
0,209  0,044  VEGF expression inhibitor
0,167  0,003  Vanilloid 2 antagonist
0,179  0,016  Estrogen antagonist
0,168  0,007  Ornithine decarboxylase inhibitor
0,213  0,053  UGT1A4 substrate
0,186  0,027  Interleukin 4 antagonist
0,176  0,019  Photosensitizer
0,170  0,014  NAD(P)H dehydrogenase (quinone) inhibitor
0,178  0,022  Alcohol dehydrogenase substrate
0,205  0,049  Eye irritation, high
0,213  0,058  Hepatoprotectant
0,267  0,112  Apoptosis antagonist
0,182  0,029  Retinoprotector
0,245  0,096  Antineoplastic (melanoma)
0,154  0,005  SULT1A2 substrate
0,193  0,046  Phospholipase A2 inhibitor
0,160  0,014  Estrogen receptor beta antagonist
0,271  0,128  Stroke treatment
0,175  0,032  Glutathione S-transferase substrate
0,155  0,015  Anabolic
0,190  0,052  Phospholipase C inhibitor
0,209  0,071  Antiarrhythmic
0,189  0,053  Antirickettsial
0,185  0,050  UGT2B10 substrate
0,245  0,112  Prostate cancer treatment
0,197  0,064  Myocardial ischemia treatment
0,224  0,094  Antineoplastic (renal cancer)
0,165  0,036  Antihemorrhagic
0,148  0,021  Alcohol dehydrogenase inhibitor
0,214  0,088  Cytostatic
0,155  0,029  Papain-like protease (SARS coronavirus) inhibitor
0,138  0,015  Aromatase inhibitor
0,255  0,134  Antineoplastic (small cell lung cancer)
0,178  0,057  Protein-tyrosine phosphatase inhibitor
0,288  0,168  Calcium channel L-type activator
0,163  0,043  Skin irritative effect
0,174  0,055  UGT2B9 substrate
0,153  0,035  Ca2+-transporting ATPase inhibitor
0,165  0,048  Bone formation stimulant
0,181  0,064  Prostatic (benign) hyperplasia treatment
0,224  0,107  Immunostimulant
0,223  0,108  Antiosteoporotic
0,147  0,032  Carbonic anhydrase XV inhibitor
0,118  0,005  TRPM8 blocker
0,140  0,027  DOPA decarboxylase inhibitor
0,158  0,044  Farnesoid X receptor antagonist
0,148  0,035  Xanthine oxidase inhibitor
0,172  0,060  Uterine stimulant
0,166  0,054  Antiacne
0,144  0,032  Aldehyde dehydrogenase substrate
0,175  0,063  Muscular dystrophy treatment
0,165  0,054  Skeletal muscle relaxant
0,231  0,121  CYP2D6 inhibitor
0,147  0,036  Contraceptive female
0,113  0,004  Retinoid X receptor agonist
0,170  0,065  Arachidonic acid antagonist
0,166  0,061  Interferon gamma antagonist
0,143  0,039  Endometrios treatment
0,154  0,050  Toll-Like receptor 2 antagonist
0,162  0,059  Antiparkinsonian, tremor relieving
0,117  0,016  Leukotriene antagonist
0,155  0,054  Nav1.2 sodium channel blocker
0,119  0,020  Prostaglandin-E synthase inhibitor
0,113  0,013  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,222  0,124  CYP2D6 substrate
0,107  0,009  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,148  0,052  Heat shock protein 70 antagonist
0,120  0,025  Phosphodiesterase 6D inhibitor
0,203  0,110  Antiviral (West Nile virus)
0,189  0,096  Cardiodepressant
0,140  0,048  Gastritis treatment
0,141  0,049  Protein-tyrosine phosphatase 1B inhibitor
0,189  0,097  Antineoplastic enhancer
0,129  0,038  Carbonic anhydrase III inhibitor
0,117  0,030  Carbonic anhydrase XIII inhibitor
0,219  0,133  Metabolic disease treatment
0,120  0,033  Androgen antagonist
0,087  0,004  ATP citrate lysase inhibitor
0,116  0,033  ABCA1 expression enhancer
0,099  0,017  Estrogen agonist
0,184  0,103  Angiogenesis stimulant
0,107  0,026  Vanilloid agonist
0,114  0,034  SULT1E1 substrate
0,214  0,135  Hypoxia-inducible factor 1 alpha inhibitor
0,104  0,026  Peroxisome proliferator-activated receptor gamma agonist
0,096  0,018  Maillard reaction inhibitor
0,142  0,064  Psychosexual dysfunction treatment
0,109  0,033  Bile acid receptor antagonist
0,236  0,164  Calcium channel activator
0,165  0,093  Antihelmintic
0,100  0,027  Lipase inhibitor
0,088  0,017  Glutamate (mGluR6) antagonist
0,132  0,060  Aldehyde dehydrogenase inhibitor
0,223  0,152  Interleukin 2 agonist
0,098  0,029  CDC25A inhibitor
0,207  0,138  Gastrin inhibitor
0,097  0,028  Leukotriene synthesis inhibitor
0,083  0,014  Leukotriene B4 antagonist
0,207  0,139  Antineoplastic (multiple myeloma)
0,121  0,054  Carcinogenic, group 2B
0,089  0,022  Endocannabinoid uptake inhibitor
0,083  0,017  Peroxisome proliferator-activated receptor alpha agonist
0,189  0,125  DNA damaging
0,093  0,029  Cannabinoid receptor agonist
0,109  0,045  UGT2B11 substrate
0,088  0,024  Peroxisome proliferator-activated receptor gamma antagonist
0,172  0,109  Antiparasitic
0,159  0,098  Wound healing agent
0,078  0,017  Sphingosine kinase inhibitor
0,169  0,108  Anticonvulsant
0,189  0,129  Antiprotozoal (Trypanosoma)
0,172  0,113  Antiparkinsonian, rigidity relieving
0,106  0,047  Lanosterol 14 alpha demethylase inhibitor
0,093  0,035  Keratolytic
0,211  0,153  Caspase 3 stimulant
0,153  0,096  ATPase inhibitor
0,059  0,004  Thiazolidinedione
0,093  0,039  CYP2A6 inhibitor
0,156  0,103  LDLR expression enhancer
0,090  0,038  Interferon agonist
0,068  0,016  Estrogen receptor beta agonist
0,241  0,190  Analgesic
0,165  0,116  Antiulcerative
0,141  0,092  Movement disorders treatment
0,104  0,056  Creatine kinase inhibitor
0,098  0,051  Thioredoxin inhibitor
0,062  0,018  Mineralocorticoid receptor antagonist
0,047  0,003  Vanilloid 2 agonist
0,064  0,021  Leukotriene C antagonist
0,095  0,053  Restless leg syndrome treatment
0,054  0,013  Glucocorticoid antagonist
0,070  0,029  Transcription factor RelA inhibitor
0,058  0,019  Cholesterol esterase inhibitor
0,141  0,103  Interleukin 6 antagonist
0,088  0,050  Glutathione S-transferase inhibitor
0,069  0,032  Antimycoplasmal
0,066  0,029  Fatty acid synthase inhibitor
0,161  0,125  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,088  0,052  Antineoplastic antibiotic
0,140  0,106  Dual specificity phosphatase inhibitor
0,131  0,097  Antifungal (Cryptococcus)
0,040  0,008  Sodium/glucose cotransporter 2 inhibitor
0,056  0,024  Potassium channel Kv1.3 blocker
0,110  0,078  Alkylator
0,049  0,017  Estrogen receptor alpha agonist
0,092  0,060  GST P1-1 substrate
0,061  0,030  Sphingosine kinase 2 inhibitor
0,148  0,117  Succinate dehydrogenase inhibitor
0,048  0,018  Sphingosine kinase 1 inhibitor
0,040  0,010  Calcium-independent phospholipase A2 inhibitor
0,149  0,120  Phobic disorders treatment
0,161  0,132  Antineoplastic (cervical cancer)
0,112  0,084  Antifungal (Pneumocystis)
0,063  0,036  Beta 2 adrenoreceptor agonist
0,136  0,109  Carcinogenic, group 1
0,089  0,063  Paget's disease treatment
0,158  0,132  Aldehyde oxidase inhibitor
0,148  0,122  Sepsis treatment
0,066  0,041  Interferon inducer
0,067  0,041  HIV-1 integrase (3'-Processing) inhibitor
0,160  0,135  Cyclic AMP phosphodiesterase inhibitor
0,059  0,034  Pregnane X receptor antagonist
0,059  0,034  Acetyl-CoA transferase 2 inhibitor
0,044  0,020  Progesterone antagonist
0,033  0,009  Sodium/glucose cotransporter inhibitor
0,179  0,155  DNA synthesis inhibitor
0,126  0,103  Insulin secretagoues
0,042  0,020  Leukotriene C4 antagonist
0,058  0,035  Cannabinoid CB2 receptor agonist
0,035  0,014  Leukotriene B4 receptor 1 antagonist
0,133  0,112  Dual specificity phosphatase 3 inhibitor
0,031  0,010  Toll-Like receptor 4 agonist
0,079  0,059  Glycine receptor antagonist
0,055  0,035  Alpha tubulin antagonist
0,088  0,069  Uric acid excretion stimulant
0,139  0,120  Platelet adhesion inhibitor
0,090  0,072  Sphingomyelinase inhibitor
0,053  0,037  Acetyl-CoA transferase inhibitor
0,043  0,026  Liver X receptor alpha agonist
0,070  0,055  Glycine receptor agonist
0,044  0,029  Liver X receptor agonist
0,036  0,023  Retinoid X alpha receptor agonist
0,053  0,040  Thromboxane synthase inhibitor
0,186  0,173  Antineoplastic (lung cancer)
0,027  0,014  Sodium/glucose cotransporter 1 inhibitor
0,052  0,041  Sphingosine 1-phosphate receptor 5 agonist
0,094  0,082  Choleretic
0,024  0,013  Leukotriene B4 receptor 2 antagonist
0,089  0,079  Urease inhibitor
0,060  0,050  CDC25B inhibitor
0,039  0,028  Retinoic acid alpha receptor agonist
0,065  0,055  Elastase 1 inhibitor
0,137  0,127  Hearing loss treatment
0,066  0,056  Andropause treatment
0,036  0,027  5-Alpha-reductase inhibitor
0,037  0,028  Retinoid X receptor antagonist
0,122  0,113  Antidiarrheal
0,051  0,042  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,024  0,015  Retinoic acid receptor agonist
0,054  0,046  HIV-1 integrase (Strand Transfer) inhibitor
0,034  0,026  Adenosine uptake inhibitor
0,069  0,061  Na+ K+ transporting ATPase inhibitor
0,176  0,169  Antihypoxic
0,061  0,054  Sphingosine 1-phosphate receptor 4 agonist
0,099  0,092  MAO inhibitor
0,079  0,072  Estrogen-related receptor beta agonist
0,018  0,012  Progesterone agonist
0,087  0,082  Topoisomerase I inhibitor
0,141  0,138  Toxic, respiratory center
0,040  0,037  Geranyltranstransferase inhibitor
0,057  0,055  Antiviral (Parainfluenza)
0,117  0,115  Antiprotozoal (Coccidial)
0,018  0,016  Peroxisome proliferator-activated receptor alpha antagonist
0,027  0,026  Lysophosphatidic acid 2 receptor antagonist
0,156  0,156  Myocardial infarction treatment
0,085  0,085  Antithrombocytopenic

